FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
+16.05%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$81.2M
AUM Growth
+$81.2M
(+8.2%)
Cap. Flow
-$1.5M
Cap. Flow
% of AUM
-1.85%
Top 10 Holdings %
Top 10 Hldgs %
49.87%
Holding
239
New
39
Increased
22
Reduced
22
Closed
43
Top Buys
| 1 |
Procter & Gamble
PG
|
$3.95M |
| 2 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.38M |
| 3 |
Bristol-Myers Squibb
BMY
|
$2.07M |
| 4 |
iShares Biotechnology ETF
IBB
|
$2.03M |
| 5 |
MON
Monsanto Co
MON
|
$1.77M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$7.18M |
| 2 |
Cal-Maine
CALM
|
$3.64M |
| 3 |
Biogen
BIIB
|
$3.54M |
| 4 |
Apple
AAPL
|
$2.93M |
| 5 |
ALR
Alere Inc
ALR
|
$2.22M |
Sector Composition
| 1 | Healthcare | 62.1% |
| 2 | Consumer Staples | 8.9% |
| 3 | Consumer Discretionary | 8% |
| 4 | Technology | 5.2% |
| 5 | Materials | 4.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
General Mills
GIS
$26.4B
| $1.12M | 0.89% |
+17,506
| New | +$1.12M |
|
27
Five Below
FIVE
$8B
| $1M | 0.79% |
24,830
+10,135
| +69% | +$408K |
|
28
TJX Companies
TJX
$152B
| $966K | 0.77% |
+12,914
| New | +$966K |
|
29
Bank OZK
OZK
$5.91B
| $909K | 0.72% |
23,675
+21,175
| +847% | +$813K |
|
|
AGN
30
DELISTED
Allergan plc
AGN
| $764K | 0.61% |
3,316
-722
| -18% | -$166K |
|
31
Meta Platforms (Facebook)
META
$1.86T
| $744K | 0.59% |
+5,800
| New | +$744K |
|
32
Coca-Cola
KO
$297B
| $633K | 0.5% |
+14,961
| New | +$633K |
|
|
AERI
33
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $628K | 0.5% |
+16,630
| New | +$628K |
|
34
IBM
IBM
$227B
| $623K | 0.49% |
3,925
+3,825
| +3,825% | +$607K |
|
|
SAGE
35
DELISTED
Sage Therapeutics
SAGE
| $588K | 0.47% |
12,778
+4,005
| +46% | +$184K |
|
36
Vertex Pharmaceuticals
VRTX
$100B
| $584K | 0.46% |
+6,694
| New | +$584K |
|
37
Heron Therapeutics
HRTX
$207M
| $516K | 0.41% |
29,937
+24,781
| +481% | +$427K |
|
38
Home Depot
HD
$405B
| $515K | 0.41% |
4,000
+500
| +14% | +$64.4K |
|
39
SCYNEXIS
SCYX
$34.9M
| $506K | 0.4% |
130,733
-25,179
| -16% | -$97.5K |
|
|
SPLK
40
DELISTED
Splunk Inc
SPLK
| $466K | 0.37% |
7,940
-1,287
| -14% | -$75.5K |
|
41
Microsoft
MSFT
$3.77T
| $441K | 0.35% |
7,657
-5,688
| -43% | -$328K |
|
42
Dell
DELL
$82.6B
| $440K | 0.35% |
+9,210
| New | +$440K |
|
43
Larimar Therapeutics
LRMR
$310M
| $437K | 0.35% |
131,930
+107,000
| +429% | +$354K |
|
44
Alibaba
BABA
$322B
| $434K | 0.34% |
4,100
+2,900
| +242% | +$307K |
|
|
NBRV
45
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $414K | 0.33% |
58,055
+8,500
| +17% | +$60.6K |
|
|
TSRO
46
DELISTED
TESARO, Inc.
TSRO
| $405K | 0.32% |
4,045
-2,963
| -42% | -$297K |
|
47
CyberArk
CYBR
$22.8B
| $362K | 0.29% |
+7,300
| New | +$362K |
|
48
Charter Communications
CHTR
$36.3B
| $355K | 0.28% |
1,315
+240
| +22% | +$64.8K |
|
49
KLA
KLAC
$115B
| $350K | 0.28% |
5,017
+3,300
| +192% | +$230K |
|
|
MNK
50
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $349K | 0.28% |
+5,004
| New | +$349K |
|